4D Molecular Therapeutics, Inc. - Common Stock (FDMT)

CUSIP: 35104E100

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / Common Stock
Shares outstanding
50,943,214
Total 13F shares
24,702,968
Share change
+3,985,023
Total reported value
$541,790,297
Price per share
$21.94
Number of holders
77
Value change
+$81,054,878
Number of buys
62
Number of sells
14

Quarterly Holders Quick Answers

What is CUSIP 35104E100?
CUSIP 35104E100 identifies FDMT - 4D Molecular Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of FDMT - 4D Molecular Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
VIKING GLOBAL INVESTORS LP
13F
Company
7.7%
3,937,914
$106,206,000 30 Sep 2021
13F
BVF INC/IL
13F
Company
3.9%
2,005,862
$54,098,000 30 Sep 2021
13F
JANUS HENDERSON GROUP PLC
13F
Company
3%
1,521,103
$41,032,000 30 Sep 2021
13F
BlackRock Finance, Inc.
13F
Company
2.8%
1,438,363
$38,794,000 30 Sep 2021
13F
Casdin Capital, LLC
13F
Company
2.2%
1,115,455
$30,084,000 30 Sep 2021
13F
Aquilo Capital Management, LLC
13F
Company
2.2%
1,099,944
$29,665,000 30 Sep 2021
13F
FMR LLC
13F
Company
2%
1,021,973
$27,562,000 30 Sep 2021
13F
ArrowMark Colorado Holdings LLC
13F
Company
2%
1,003,447
$27,063,000 30 Sep 2021
13F
VANGUARD GROUP INC
13F
Company
1.9%
945,977
$25,513,000 30 Sep 2021
13F
Octagon Capital Advisors LP
13F
Company
1.6%
831,267
$22,419,000 30 Sep 2021
13F
David Schaffer
3/4/5
Director
class O/S missing
901,215
$16,589,476 20 Oct 2021
ALKEON CAPITAL MANAGEMENT LLC
13F
Company
1.2%
602,225
$16,243,000 30 Sep 2021
13F
PERCEPTIVE ADVISORS LLC
13F
Company
0.74%
375,256
$10,121,000 30 Sep 2021
13F
MORGAN STANLEY
13F
Company
0.72%
368,439
$9,937,000 30 Sep 2021
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.67%
342,218
$9,229,000 30 Sep 2021
13F
STATE STREET CORP
13F
Company
0.63%
319,662
$8,621,000 30 Sep 2021
13F
Laurion Capital Management LP
13F
Company
0.54%
275,123
$7,421,000 30 Sep 2021
13F
Centiva Capital, LP
13F
Company
0.7%
358,863
$7,220,000 30 Sep 2021
13F
JPMORGAN CHASE & CO
13F
Company
0.45%
229,936
$6,201,000 30 Sep 2021
13F
NORTHERN TRUST CORP
13F
Company
0.37%
189,825
$5,119,000 30 Sep 2021
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.3%
155,258
$4,187,000 30 Sep 2021
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.28%
145,154
$3,915,000 30 Sep 2021
13F
Soleus Capital Management, L.P.
13F
Company
0.24%
120,900
$3,261,000 30 Sep 2021
13F
Nuveen Asset Management, LLC
13F
Company
0.18%
90,902
$3,164,000 30 Sep 2021
13F
Russell Investments Group, Ltd.
13F
Company
0.2%
102,717
$2,770,000 30 Sep 2021
13F
Woodline Partners LP
13F
Company
0.17%
86,423
$2,331,000 30 Sep 2021
13F
Bank of New York Mellon Corp
13F
Company
0.14%
69,218
$1,867,000 30 Sep 2021
13F
Eagle Health Investments LP
13F
Company
0.11%
57,090
$1,540,000 30 Sep 2021
13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC
13F
Company
0.08%
42,532
$1,147,000 30 Sep 2021
13F
Swiss National Bank
13F
Company
0.06%
29,600
$798,000 30 Sep 2021
13F
RHUMBLINE ADVISERS
13F
Company
0.05%
24,538
$662,000 30 Sep 2021
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.04%
22,265
$600,000 30 Sep 2021
13F
DEUTSCHE BANK AG\
13F
Company
0.03%
16,861
$454,000 30 Sep 2021
13F
SG Americas Securities, LLC
13F
Company
0.03%
14,197
$383,000 30 Sep 2021
13F
MIRABELLA FINANCIAL SERVICES LLP
13F
Company
0.03%
14,080
$380,000 30 Sep 2021
13F
CITADEL ADVISORS LLC
13F
Company
0.03%
13,836
$373,000 30 Sep 2021
13F
STATE OF WISCONSIN INVESTMENT BOARD
13F
Company
0.03%
12,800
$345,000 30 Sep 2021
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.02%
12,623
$341,000 30 Sep 2021
13F
VICTORY CAPITAL MANAGEMENT INC
13F
Company
0.02%
12,259
$331,000 30 Sep 2021
13F
M&T BANK CORP
13F
Company
0.02%
11,648
$314,000 30 Sep 2021
13F
AMERICAN INTERNATIONAL GROUP, INC.
13F
Company
0.02%
11,468
$309,000 30 Sep 2021
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0.02%
11,178
$301,000 30 Sep 2021
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.02%
9,686
$261,000 30 Sep 2021
13F
Resolute Advisors LLC
13F
Company
0.02%
9,621
$259,000 30 Sep 2021
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.02%
9,495
$256,000 30 Sep 2021
13F
CREDIT SUISSE AG/
13F
Company
0.02%
8,930
$241,000 30 Sep 2021
13F
VOYA INVESTMENT MANAGEMENT LLC
13F
Company
0.02%
8,150
$220,000 30 Sep 2021
13F
MetLife Investment Management, LLC
13F
Company
0.02%
7,979
$215,194 30 Sep 2021
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.02%
7,684
$206,000 30 Sep 2021
13F
VIRTUS ADVISERS, LLC
13F
Company
0.01%
7,257
$196,000 30 Sep 2021
13F

Institutional Holders of 4D Molecular Therapeutics, Inc. - Common Stock (FDMT) as of Q4 2021

As of 31 Dec 2021, 4D Molecular Therapeutics, Inc. - Common Stock (FDMT) was held by 77 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 24,702,968 shares. The largest 10 holders included VIKING GLOBAL INVESTORS LP, BlackRock Inc., BVF INC/IL, Deep Track Capital, LP, JANUS HENDERSON GROUP PLC, Octagon Capital Advisors LP, Aquilo Capital Management, LLC, VANGUARD GROUP INC, STATE STREET CORP, and FMR LLC. This page lists 77 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders
61
Q4 2021 holders
77
Holder diff
16
Investor Q3 2021 Shares Q4 2021 Shares Share Diff Share Chg % Q3 2021 Value $ Q4 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.